Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation

Tim Kees1, Jennifer Lohr, Johannes Noack

  • 1INSERM U701, German Cancer Research Centre, INF 242, Germany.

Neuro-Oncology
|October 22, 2011
PubMed

Insights

Human microglia initially support glioma growth but become tumor-suppressive after Toll-like receptor 3 stimulation. This shift demonstrates a novel therapeutic strategy targeting brain tumors.

Area of Science:

  • Neuroscience
  • Immunology
  • Oncology

Background:

  • Microglia, the brain's immune cells, have a debated role in glioma, a type of brain tumor.
  • Existing research suggests microglia and macrophages may promote glioma progression.

Purpose of the Study:

  • To investigate the dual role of human microglia in glioma biology.
  • To determine if microglia can be modulated to exert anti-tumor effects.

Main Methods:

  • Isolation of human microglia from brain tumors.
  • Co-culture experiments with glioblastoma cells.
  • Stimulation of microglia with poly (I:C) (Toll-like receptor 3 agonist).
  • Assays for cytotoxicity, migration, invasion, and spheroid growth.

Main Results:

  • Human microglia isolated from tumors supported glioma cell growth, migration, and invasion.
  • Poly (I:C) stimulation induced microglia to secrete factors toxic to glioblastoma cells.
  • These microglial-derived factors did not affect neurons or astrocytes.
  • Tumor cells partially inhibited the poly (I:C)-induced anti-tumor microglial response.

Conclusions:

  • Human microglia possess both tumor-supportive and tumor-suppressive functions in glioma.
  • Microglial anti-tumor activity can be induced via Toll-like receptor 3 stimulation.
  • Modulating microglia represents a potential therapeutic avenue for glioblastoma.

Related Concept Videos